Unilever NV (UN)
(Delayed Data from NYSE)
$60.09 USD
+0.61 (1.03%)
Updated May 3, 2019 04:01 PM ET
After-Market: $60.09 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$60.09 USD
+0.61 (1.03%)
Updated May 3, 2019 04:01 PM ET
After-Market: $60.09 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Nu Skin (NUS) Tops Q3 Earnings Estimates, Raises 2020 View
by Zacks Equity Research
Strong growth in sales leaders and customer base, as well as robust digital growth drive Nu Skin's (NUS) performance for third-quarter 2020.
The Zacks Analyst Blog Highlights: Whirlpool, Newell Brands, Carrier Global Corp and Unilever
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Whirlpool, Newell Brands, Carrier Global Corp and Unilever
4 Air Purifier Stocks to Watch on Growing Demand Amid Pandemic
by Ritujay Ghosh
Air purifiers can, to a large extent, help people who are suffering from asthma, airborne allergies and other breathing disorders.
The Zacks Analyst Blog Highlights: Whirlpool, Philips, Johnson Controls International and Unilever
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Whirlpool, Philips, Johnson Controls International and Unilever
Wildfires, Pandemic Boosting Air Purifier Demand: 4 Winners
by Ritujay Ghosh
Air purifiers can, to a large extent, help people who are suffering from asthma, airborne allergies and other breathing disorders.
Air Purifiers Gain Prominence in Pandemic World: 4 Winners
by Ritujay Ghosh
Since COVID-19 is airborne, air purifiers have seen a surge in residential and commercial demand as a preventive measure.
Top Ranked Value Stocks to Buy for July 31st
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, July 31st.
Unilever's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in The Unilever.
Air Purifiers Gain Prominence as Coronavirus Prevention: 4 Picks
by Ritujay Ghosh
Since COVID-19 is airborne, air purifiers have seen a surge in residential and commercial demand in the past few months as a preventive measure.
Coronavirus Ups Demand for Air Purifiers: 4 Stocks to Watch
by Manaswita Ghosh Dutta
More consumers are demanding HEPA filters amid the COVID-19 outbreak, thus leading to a significant rise in demand for air purifiers.
Buy Clorox (CLX) Stock Now for Coronavirus Volatility and Beyond?
by Benjamin Rains
Clorox shares have surged 35% in 2020 to crush the S&P 500's 5% decline as its disinfectant wipes fly off the shelves during the coronavirus pandemic. With this in mind, investors might want to consider buying CLX stock as coronavirus volatility returns...
Is Clorox (CLX) Stock Still a Great Buy for the Eventual Coronavirus Recovery?
by Benjamin Rains
Clorox topped our quarterly earnings and revenue estimates on May 1, and the stock has jumped 12% since the end of April. Some investors might think the rally is overdone. But is Clorox still a great buy even near its new highs?
3 Highly-Ranked Stocks to Buy for the Coronavirus Economy & the Eventual Recovery
by Benjamin Rains
On today's episode of Full Court Finance, we explore three stocks that appear to be buys at the moment and down the road when the economy eventually turns around from the coronavirus downturn...
Why Clorox (CLX) Stock is a Long-Term Buy Far Beyond the Coronavirus
by Benjamin Rains
Clorox sells disinfectant products that kill germs at home and in healthcare settings, which makes it almost tailor-made for the coronavirus economy. Better still, Clorox's portfolio is far more diverse and CLX appears to be a solid longer-term buy...
Ecolab's (ECL) Gallay Medical Buyout to Boost Healthcare Arm
by Zacks Equity Research
The addition of Gallay Medical is likely to boost Ecolab's (ECL) Healthcare offerings.
Ecolab's Chemstar Buyout to Boost Food & Beverage Business
by Zacks Equity Research
Chemstar's flagship Sterilox Fresh to help boost Ecolab's (ECL) Food & Beverage unit.
Soap & Cleaning Materials Industry Outlook Upbeat on New Products
by Rajani Lohia
The FMCG space is likely to gain from investment in brands, innovation, cost-containment and pricing actions. However, its struggles against higher raw material and transportation costs continue.
Estee Lauder (EL) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Estee Lauder (EL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Procter & Gamble Moves Up the Charts: Will Growth Continue?
by Zacks Equity Research
Procter & Gamble (PG) emphasizes on improving its product portfolio through strategic initiatives. Also, the company is on track with its cost-saving plans.
5 Top European Stocks to Buy on ECB's Hints of More Stimulus
by Sanghamitra Saha
The ECB hints at more policy stimulus, making the conditions favorable for these stocks.
Church & Dwight Sales to Gain on International Unit & More
by Zacks Equity Research
Church & Dwight's (CHD) top line has been impressive for a while, gaining from strong Consumer International unit, buyouts and innovation.
UN or CL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UN vs. CL: Which Stock Is the Better Value Option?
Kimberly-Clark (KMB) Stock Up on Q1 Earnings & Sales Beat
by Zacks Equity Research
Kimberly-Clark's (KMB) top and bottom lines beat the Zacks Consensus Estimate in Q1. However, cost woes lingered.
Estee Lauder (EL) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Estee Lauder (EL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
UN or CL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UN vs. CL: Which Stock Is the Better Value Option?